The Combination of MK-5172, Peginterferon, and Ribavirin Is Effective in Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Infection Without Cirrhosis-Reference-Cited by-同舟云学术

The Combination of MK-5172, Peginterferon, and Ribavirin Is Effective in Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Infection Without Cirrhosis

Published:2014-08 Issue:2 Volume:147 Page:366-376.e6
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Manns Michael P.,Vierling John M.,Bacon Bruce R.,Bruno Savino,Shibolet Oren,Baruch Yaacov,Marcellin Patrick,Caro Luzelena,Howe Anita Y.M.,Fandozzi Christine,Gress Jacqueline,Gilbert Christopher L.,Shaw Peter M.,Cooreman Michael P.,Robertson Michael N.,Hwang Peggy,Dutko Frank J.,Wahl Janice,Mobashery Niloufar

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference24 articles.

1. Novel therapies for hepatitis C - one pill fits all?;Manns;Nat Rev Drug Discov,2013

2. The way forward in HCV treatment–finding the right path;Manns;Nat Rev Drug Discov,2007

3. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial;Manns;Lancet,2001

4. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

5. Sustained virologic response to antiviral therapy for chronic hepatitis C virus infection: a cure and so much more;Pearlman;Clin Infect Dis,2011

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ERKRANKUNGEN DER VERDAUUNGSORGANE;Rationelle Diagnostik und Therapie in der Inneren Medizin;2020

2. Pharmacokinetic Interactions Between the Fixed‐Dose Combinations of Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine and Elbasvir/Grazoprevir in Healthy Adult Participants;Clinical Pharmacology in Drug Development;2019-10

3. New Direct-Acting Antivirals for the Treatment of Patients With Hepatitis C Virus Infection: A Systematic Review of Randomized Controlled Trials;Journal of Clinical and Experimental Hepatology;2019-07

4. Near-Neighbor Interactions in the NS3-4A Protease of HCV Impact Replicative Fitness of Drug-Resistant Viral Variants;Journal of Molecular Biology;2019-05

5. Pharmacokinetic Interactions between the Hepatitis C Virus Inhibitors Elbasvir and Grazoprevir and HIV Protease Inhibitors Ritonavir, Atazanavir, Lopinavir, and Darunavir in Healthy Volunteers;Antimicrobial Agents and Chemotherapy;2019-02-11